This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Diastematomyelia척수이개증

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q06.2 (diastematomyelia) | Special Copayment Reduction: V180 (rare disease)
B. Synonyms—
C. Adult onsetLikelihood of first onset in adulthood not low — diastematomyelia is a congenital malformation, but when symptoms are mild or absent, it is not uncommonly left undiagnosed into adulthood. In particular, in the form in which the split cord halves have no bony spur (Type II), some patients without childhood symptoms first present in adulthood with low back pain, lower limb abnormalities, or impaired bladder function and are then diagnosed.
1. HistoryFirst described by Ollivier in 1837. Pang's 1992 classification (Type I: bony spur, Type II: fibrous septum) is the current standard. Spinal cord untethering is the key treatment to prevent neurologic progression.
2. CausesThe endodermal-ectodermal adhesion theory (Bentley-Smith theory) is the leading explanation of pathogenesis. Abnormal median septum formation after notochordal splitting. Possible association with folate deficiency-related NTDs.
3. GeneticsMostly sporadic. Some cases accompanied by spina bifida or VATER/VACTERL-associated complex malformations. No specific single-gene defect established. Recurrence risk in genetic counseling is relatively low.
4. General epidemiologyReported in about 2–4% of all spina bifida. Isolated occurrence is rare (1/5,000–10,000 births). About 1.5–3 times more common in girls. The thoracolumbar junction is the most common level.
5. PathophysiologyNotochordal splitting at 4–8 weeks of gestation → abnormal endodermal-ectodermal junction → formation of a bony spur or fibrous septum → division of the spinal cord into two halves. Cord tethering → neural traction injury during growth.
6. SymptomsLower limb weakness (may be asymmetric), scoliosis, skin findings (midline back nevus, dimple, lipoma), bladder and bowel dysfunction, low back pain (adults), lower limb pain or sensory abnormalities.
7. SignsAsymmetric lower limb strength, reflexes, and muscle atrophy, foot deformity (unilateral equinus), midline back skin abnormalities, scoliosis. Separation of the cord into two halves and a median septum (bony spur/fibrous septum) confirmed on MRI.
8. ScreeningSpinal MRI/ultrasound when congenital skin findings (back dimple, lipoma, nevus) are found. Detected as an associated finding on spinal MRI of spina bifida patients. When abnormal findings are present, it can be suspected prenatally on fetal MRI/ultrasound.
9. DiagnosisSpinal MRI (T1/T2, coronal reconstruction) is the standard. CT for accurate assessment of the presence and extent of a bony spur. Myelography is now rarely used. Electrophysiologic tests (SSEP, EMG) to assess neural function.
10. TreatmentSurgical septum resection and spinal cord untethering when symptomatic or when there is a risk of progressive tethering during growth. Observation for asymptomatic, nonprogressive cases. Concurrent management of associated malformations.
11. PrognosisEarly surgery can achieve neurologic stabilization. Complete recovery from existing neural damage is limited. Preventing cord retethering is the key to long-term management. Non-neurologic prognosis (quality of life) depends on access to treatment.
12. PreventionNo specific primary prevention. Early detection of skin findings, early spinal MRI, and timely surgery to prevent neurologic progression. Folic acid supplementation recommended as for associated NTDs.
13. ReferencesPang D et al. Neurosurgery 1992; Gupta DK et al. Child Nerv Syst 2008 and 8 others

1. History

Diastematomyelia is a rare congenital spinal cord malformation in which the spinal cord is split longitudinally into two halves. The term derives from the Greek 'diastema' (gap, cleft) and 'myelos' (spinal cord). The first systematic description was made in 1837 by the French neuropathologist Ollivier d'Angers, who reported a spinal cord split into two halves at autopsy.

From the late 19th to the early 20th century, many sporadic cases were reported, but without a classification system, names and definitions were confusing. With advances in radiologic technology and the introduction of myelography in the 1950s–60s, diagnosis in living patients became possible. In 1974, Whitehouse and Adler systematized the principles of surgical treatment of diastematomyelia.

The most important classification system is the one proposed by Dachling Pang in 1992. Pang divided cord splitting into two types: Type I (Split Cord Malformation I, SCM I), in which each half lies within a separate dural sheath with a rigid septum (usually a bony spur or cartilage) between the dural sheaths, and Type II (SCM II), in which the two halves lie within a single dural sheath and are separated by a fibrous soft-tissue septum. This classification is practical for determining surgical indications and prognosis and is currently used as the standard. Pang also referred to both types collectively as 'split cord malformation (SCM)'.

The spread of MRI (1980s–90s) revolutionized the diagnosis of diastematomyelia. Cord splitting, septum morphology, cord tethering, and associated malformations could be assessed accurately without invasive myelography. Recently, cases of prenatal diagnosis by fetal MRI have also been reported, and 3D CT reconstruction has enabled precise anatomic assessment of bony spurs. In Korea, a multidisciplinary approach to patients with diastematomyelia is provided by pediatric neurosurgery and pediatric rehabilitation medicine, and when registered as a disease eligible for the rare disease Special Copayment Reduction V180, patients receive a reduced copayment.

2. Causes

The cause of diastematomyelia is explained by splitting of the notochord in early embryogenesis and the resulting formation of an abnormal tissue septum. The most widely accepted mechanism is the entodermal-ectodermal adhesion theory proposed by Bentley and Smith in 1961.

In normal embryogenesis, at about 3–4 weeks of gestation when the neural plate forms, separation is normally maintained between the endoderm (gut lining) anterior to the notochord and the ectoderm (dorsal skin) posterior to it. According to the endodermal-ectodermal adhesion theory, the two germ layers adhere abnormally, and the notochord splits into left and right branches as it bypasses the site of adhesion. An abnormal mesodermal septum forms around the split notochord, and this ossifies or fibroses to form the median septum dividing the spinal cord in two. In Type I, this septum forms as a hard bony spur; in Type II, it remains a fibrous soft-tissue septum.

Diastematomyelia mostly occurs sporadically, and it is rare for a specific single-gene defect to be established as the cause. However, because it is often accompanied by other NTDs and occult spinal dysraphism such as spina bifida, myelomeningocele, and lower spinal lipoma, it is understood as part of a common developmental spectrum of abnormal neural tube formation. It also sometimes appears as part of VATER (vertebral-anorectal-tracheal-esophageal-renal complex malformation) and VACTERL-associated complex malformations. Because such associations with complex malformations are observed, a systemic evaluation for abnormalities of other organs is recommended when diastematomyelia is diagnosed.

There is as yet no clear evidence on whether folate deficiency contributes to the development of diastematomyelia, but because associated NTDs (spina bifida, etc.) are linked to folate deficiency, it is reasonable to recommend folic acid supplementation before and early in pregnancy. Common NTD risk factors such as maternal diabetes and hyperthermia may also contribute to diastematomyelia, but research on this is limited.

3. Genetics

Diastematomyelia has rarely been established as a genetic disease caused by a specific single-gene defect, and most cases are sporadic. Familial clustering is very rare, and it does not appear to follow a simple mode of inheritance. However, a multifactorial genetic predisposition may play some role, together with associated other NTDs (spina bifida, etc.).

At the molecular genetic level, no gene specifically associated with diastematomyelia has been clearly identified to date. Notch signaling, FGF signaling, and the WNT pathway are being studied as involved in notochordal splitting, but causal relationships between specific variants in these pathways and human diastematomyelia remain at the animal model level. When it appears as part of VACTERL-associated complex malformations, complex malformation-related genes such as ZIC3, FOXH1, and ACVR2B may be indirectly involved, but a direct causal relationship is unknown.

In the spina bifida and occult spinal dysraphism accompanying diastematomyelia, NTD-related genetic variants such as MTHFR polymorphisms and PCP pathway gene variants may be found. Therefore, when diastematomyelia and spina bifida coexist, it is appropriate to apply the principles of NTD-related genetic counseling. The familial recurrence risk in sporadic cases may be slightly higher than in the general population, but an exact recurrence risk figure has not been established. In genetic counseling, the low recurrence risk is explained while also considering the recurrence risk for associated NTDs (about 3–5%).

Associations with chromosomal abnormalities have also been reported. Some case reports describe diastematomyelia accompanying chromosomal abnormalities such as trisomy 18 and Turner syndrome. When diastematomyelia is suspected on prenatal diagnosis, fetal chromosome analysis or CMA is recommended to exclude associated chromosomal abnormalities. Genetic studies of diastematomyelia using genome-wide association studies (GWAS) and NGS are under way, but clinically applicable gene panels have not yet been standardized.

4. General epidemiology

Diastematomyelia is a rare congenital spinal cord malformation, and its exact incidence is difficult to determine. Because cases with mild or no symptoms may remain undiagnosed into adulthood, the actual prevalence may be higher than reported. According to existing reports, the frequency is estimated at about 1 in 5,000–10,000 births, but the diagnosis rate is increasing with the spread of MRI.

By sex, girls are reported to be affected about 1.5–3 times more often than boys. This sex difference is speculated to be due to sex hormone effects during embryogenesis or sex differences in mesodermal development, but the mechanism is still unknown. Lesions occur most commonly at the thoracolumbar junction (T10–L2 level), with frequency decreasing in the order of lumbar (L1–L5), thoracic, and sacral levels. The ratio of Type I (with bony spur) to Type II (fibrous septum) differs between reports, but they are known to occur at roughly similar frequencies.

Diastematomyelia may occur alone, but is often accompanied by other spinal cord and spinal malformations. Reported frequencies of associated malformations: scoliosis about 40–60%, spina bifida about 30–50%, tethered cord about 50–70%, lower spinal lipoma about 20–40%, and intradural dermal sinus about 10–20%. Because associations with complex malformations are so common, whole-spine MRI, brain MRI, and urologic ultrasound are essential when diastematomyelia is diagnosed.

Epidemiology in Korea: Large-scale epidemiologic data on diastematomyelia (Q06.2) in Korea are limited, but it is partly included in the congenital anomaly registry in connection with spina bifida. When registered as eligible for the rare disease Special Copayment Reduction V180, a reduced copayment is provided. Clinical experience is gradually accumulating in pediatric neurosurgery and pediatric rehabilitation medicine, and multidisciplinary management is provided at specialized diastematomyelia clinics.

5. Pathophysiology

The core pathogenesis of diastematomyelia is the splitting of the notochord into left and right branches at 4–8 weeks of gestation and the formation of an abnormal median septum around the split notochord. In normal development, the notochord is a single structure located beneath the neural tube that provides signals for neurulation and for differentiation of the spinal cord and vertebrae. When the notochord splits, the vertebrae and spinal cord form independently around each of the two separated notochords, ultimately producing a spinal cord divided into two halves (hemicords).

According to the Bentley-Smith theory, abnormal endodermal-ectodermal adhesion causes notochordal splitting. When the gut lining (endoderm) adheres abnormally to the dorsal skin (ectoderm), the notochord bypasses the site of adhesion and divides into two branches, and an abnormal septum of mixed endodermal, ectodermal, and mesodermal tissue forms around the adhesion. When this septum ossifies, it becomes a Type I bony spur (bony spur); when it fibroses, a Type II fibrous septum (fibrous band).

Mechanism of tethered cord: In diastematomyelia, the median septum between the two cord halves restricts cord movement and causes tethering. With growth, the spinal cord must ascend (normally the conus lies at the L3–L4 level in neonates and moves to L1–L2 in adults), but tethering by the septum prevents this ascent. Persistent traction causes spinal cord ischemia, impaired cellular metabolism, and neurotransmitter abnormalities, and neural function progressively declines.

Mechanism of asymmetric neural damage: When the two hemicords are pulled or compressed unequally by the septum, neurologic deficits may be asymmetric. The bony spur in Type I can directly compress the cord, damaging one half more severely. Asymmetric lower limb weakness, unilateral foot deformity, and asymmetric reflexes are the clinical expressions of this mechanism.

Mechanism of associated malformations: At the level where notochordal splitting occurs, vertebral formation is also abnormal, so vertebral formation defects such as hemivertebrae, butterfly vertebrae, and block vertebrae are present, causing scoliosis. Associated spina bifida results from a combined defect in which abnormal neural tube closure and notochordal splitting occur at the same time and at the same level.

6. Symptoms

The clinical symptoms of diastematomyelia vary depending on lesion level, Type I versus II, the size and rigidity of the septum, and the presence of associated malformations. Some patients remain asymptomatic or have only mild symptoms into adulthood, while others are born with severe neurologic deficits.

Skin and back findings: Midline back skin abnormalities are observed in about 50–80% of diastematomyelia cases. These are important diagnostic clues as cutaneous markers. Common skin findings include hair tufts, hemangiomas, dimples, lipomas, and skin pigment changes. When these skin findings are absent (about 20–50%), diagnosis may be delayed until symptoms appear.

Motor dysfunction: Lower limb weakness occurs, and when the two cord halves are damaged unequally, asymmetric weakness is characteristic. When one foot or leg is markedly smaller or weaker than the other, diastematomyelia should be suspected. Foot deformities (equinus, clubfoot) are common and may occur on one side only.

Sensory disturbances: Sensory loss or sensory abnormalities below the level of the lesion occur. Asymmetric sensory loss is suggestive of diastematomyelia. In adults, some first present with lower limb numbness, burning pain, or paresthesia.

Bladder and bowel dysfunction: Voiding dysfunction (frequency, incontinence, residual urine), constipation, and fecal incontinence may occur. In adults, bladder dysfunction may be the first symptom, so diastematomyelia should be considered in the differential diagnosis of neurogenic bladder.

Spinal deformity: When scoliosis is present, back pain and reduced cardiopulmonary function may develop as the curve progresses. When new low back pain, radiating leg pain, or gait abnormalities appear in adults, the possibility of tethered cord syndrome from previously asymptomatic diastematomyelia should be kept in mind.

7. Signs

The physical signs of diastematomyelia are assessed in terms of skin findings, neurologic findings, spinal findings, and urologic findings.

Skin and back signs: Hair tufts, hemangiomas, dimples, and lipomas are observed along the midline of the back. Scoliosis is identified on inspection by shoulder and pelvic asymmetry and rib prominence (in thoracic scoliosis). Abnormal alignment (lateral deviation, absence) of the spinous processes at the lesion level may be palpable.

Neurologic signs: Asymmetric lower limb weakness is the most characteristic. When the strength of one lower limb (mainly distally) is markedly lower than the other, or only one foot is deformed, diastematomyelia is strongly suggested. Asymmetric deep tendon reflexes (unilaterally reduced or absent), asymmetric muscle atrophy, and asymmetric foot deformity (unilateral equinus or clubfoot) are observed. Sacral cord function is assessed with the anal reflex and bulbocavernosus reflex. Upper motor neuron signs (spasticity, Babinski reflex) may be present, suggesting cord compression or an associated Chiari malformation.

Imaging signs: On spinal MRI (coronal, T1- and T2-weighted images), the finding of a spinal cord divided into two hemicords is the key diagnostic sign. The presence and morphology of the median septum (bony spur versus fibrous septum) are determined. In Type I, each half lies within a separate dural tube, with a bony spur located between the two dural tubes. CT (3D reconstruction) assesses the exact size, location, and orientation of the bony spur for surgical planning. Associated vertebral abnormalities (hemivertebrae, block vertebrae, scoliosis) are also identified on imaging.

Urologic signs: Increased post-void residual urine and abnormal bladder function on urodynamic testing may be present. On renal ultrasound, hydronephrosis and bladder wall thickening are observed as long-term urologic complications. Electromyography (EMG) may show abnormal innervation of the anal sphincter.

8. Screening

There is no population screening for diastematomyelia. The main routes of detection are ① spinal imaging when midline back skin findings are noted, ② incidental discovery during evaluation of related malformations such as spina bifida, ③ discovery during evaluation of neurologic symptoms, and ④ abnormal findings on prenatal ultrasound/MRI.

Screening based on skin findings: When skin abnormalities such as midline back hair tufts, hemangiomas, dimples, or lipomas are found at neonatal or pediatric examination, spinal imaging is performed immediately. In neonates, spinal ultrasound is a useful first-line test that can assess diastematomyelia, lipoma, dermal sinus, and cord tethering without radiation exposure. After 6 months of age, when the accuracy of spinal ultrasound declines, MRI is used instead. Among midline back skin findings, high-risk findings such as ① two or more skin abnormalities, ② a hemangioma of 5 cm or more, and ③ a dimple located above the anus are indications for immediate MRI.

Evaluation with spina bifida: Diastematomyelia is reported to be found incidentally in about 2–4% of whole-spine MRIs of patients with spina bifida (myelomeningocele, lipomyelomeningocele). Therefore, an MRI protocol scanning the entire spine is recommended when spina bifida is diagnosed.

Prenatal screening: When spinal abnormalities or asymmetric cord findings are suspected on detailed anatomic ultrasound at 18–22 weeks of gestation, fetal MRI is performed. The prenatal ultrasound detection rate of diastematomyelia is lower than that of other NTDs, but it can be suspected when the lesion is large or associated malformations are present. When diagnosed prenatally, fetal karyotyping, evaluation of associated malformations, and genetic counseling are performed together.

9. Diagnosis

Diastematomyelia is confirmed by imaging diagnosis centered on MRI. Coronal MRI best shows cord splitting, and CT is used as a complement for precise assessment of bony spurs.

Spinal MRI: Coronal, sagittal, and axial T1-weighted (T1WI) and T2-weighted (T2WI) images are all assessed. The finding of a cord separated into two hemicords on coronal MRI is the key to diagnosis. In Type I, the dural tubes around each hemicord and the bony spur located between them (hypointense on both T1 and T2) are identified. In Type II, the two hemicords are separated by a fibrous septum within a single dural tube. Cord tethering, associated lipoma, syringomyelia (syrinx), spina bifida, and Chiari malformation are assessed at the same time.

CT (3D reconstruction): Performed to determine the exact size and location (anteroposterior, left-right, and craniocaudal extent) of the Type I bony spur and its anatomic relationships within the spinal canal. It is essential for surgical planning and identifies cases with more than one bony spur. It is also useful for assessing vertebral formation defects (hemivertebrae, block vertebrae, scoliosis).

Electrophysiologic testing: Neural function is assessed with somatosensory evoked potentials (SSEP), motor evoked potentials (MEP), and electromyography (EMG). Baseline electrophysiologic data establish the extent of neural damage before surgery and provide reference values for intraoperative neuromonitoring (IONM). Asymmetric SSEP abnormalities are suggestive of diastematomyelia.

Urodynamic testing: When bladder dysfunction is present, urodynamic testing classifies the type of neurogenic bladder and guides treatment planning. The upper urinary tract is assessed with renal ultrasound and VCUG.

10. Treatment

Treatment of diastematomyelia is determined by the presence of symptoms, neurologic progression, Type, age, and associated malformations. When found incidentally in an asymptomatic adult, the decision to operate is made carefully; surgery is recommended when symptoms are present or neurologic progression is confirmed.

Surgical septum resection and spinal cord untethering: In Type I (bony spur), the main treatment is resection of the bony spur. A neurosurgeon carefully removes the bony spur by layer-by-layer dissection under the microscope, and the dura around the two cord halves is repaired or the separate dural tubes are joined into one to restore cord mobility. In Type II (fibrous septum), the cord is released by resecting the fibrous septum. An associated thickened filum terminale, lipoma, or dermal sinus is treated at the same time. Intraoperative neuromonitoring (SSEP, MEP, anal IONM) minimizes neural injury.

Timing of surgery: In children, early surgery (within a few months to a few years of birth) is recommended to prevent progression of tethering with growth. Prophylactic surgery in asymptomatic children is controversial, but many institutions perform prophylactic surgery when the risk of neurologic progression during growth is high. In adults, surgery is recommended when symptom progression is confirmed; complete recovery of existing neural damage is difficult to expect, but the effect of preventing further progression is clear.

Treatment of associated malformations: When scoliosis progresses, bracing or spinal fusion is considered. Neurogenic bladder is managed with CIC and anticholinergics. When spina bifida or myelomeningocele is present, the corresponding treatment is given concurrently.

Follow-up: After surgery, long-term follow-up uses regular neurologic examinations, spinal MRI (for cord retethering), and urodynamic testing. When followed without surgery, neurologic examination 1–2 times a year and periodic MRI are performed.

11. Prognosis

The prognosis of diastematomyelia differs greatly depending on timing of diagnosis, timing of surgery, extent of neural damage, and presence of associated malformations. Early diagnosis and timely surgery are the key to improving prognosis.

Performing surgical septum resection and spinal cord untethering before symptom onset or at an early stage of neurologic damage can stabilize neurologic function. Complete recovery of neural damage that has already occurred is limited after surgery, and long-standing motor and sensory deficits in particular are difficult to recover. However, improvement in bladder function, reduced pain, and relief of sensory abnormalities after surgery are reported. Cord retethering (re-tethering) can occur long after surgery, so regular MRI follow-up is needed. Associated scoliosis requires separate orthopedic treatment if it progresses. Cognitive function and upper limb function are mostly normal, and school and social participation are possible. Life expectancy itself is determined by the severity of neurologic complications and associated malformations.

12. Prevention

No specific primary prevention method for diastematomyelia has been established. Because the pathogenesis stems from an early embryonic event, notochordal splitting, only indirect prevention based on known risk factors is possible.

Folic acid supplementation to prevent associated NTDs: Because diastematomyelia is often accompanied by NTDs such as spina bifida, folic acid supplementation of 400–800 μg/day before and early in pregnancy is recommended to prevent associated NTDs. In high-risk groups (previously affected child, family history, valproic acid use, maternal diabetes), high-dose folic acid (5 mg/day) is prescribed. The effect of folic acid on preventing diastematomyelia itself has not yet been established.

Early detection (secondary prevention): In neonates and children, midline back skin findings are carefully checked, and when abnormal findings are present, spinal ultrasound or MRI is performed immediately for early diagnosis. When spinal abnormalities are suspected on prenatal ultrasound, they are confirmed with fetal MRI. In patients with spina bifida, whole-spine MRI screens for associated diastematomyelia. In children with asymmetric lower limb findings (unilateral foot deformity, asymmetric muscle atrophy), diastematomyelia is included in the differential diagnosis.

Prevention of complications (tertiary prevention): After diagnosis, timely surgery prevents neurologic progression due to cord tethering. Regular postoperative follow-up detects and treats cord retethering and scoliosis progression early. Regular management of neurogenic bladder preserves kidney function. Pressure ulcer prevention education and regular skin checks are important in areas of sensory loss.

13. References

  1. Pang D, Dias MS, Ahab-Barmada M. Split cord malformation. Part I: A unified theory of embryogenesis for double spinal cord malformations. Neurosurgery. 1992;31(3):451-480. DOI: 10.1227/00006123-199209000-00009. PMID: 1407427.
  2. Pang D. Split cord malformation. Part II: Clinical syndrome. Neurosurgery. 1992;31(3):481-500. DOI: 10.1227/00006123-199209000-00010. PMID: 1407428.
  3. Gupta DK, Mahapatra AK. Diastematomyelia and split cord malformations. Childs Nerv Syst. 2013;29(9):1485-1492. DOI: 10.1007/s00381-013-2149-y. PMID: 23942802.
  4. Hilal SK, Marton D, Pollack E. Diastematomyelia in children: radiographic study of 34 cases. Radiology. 1974;112(3):609-621. DOI: 10.1148/112.3.609. PMID: 4842217.
  5. Ersahin Y, Mutluer S, Kocaman S, Demirtaş E. Split spinal cord malformations in children. J Neurosurg. 1998;88(1):57-65. DOI: 10.3171/jns.1998.88.1.0057. PMID: 9420073.
  6. Miller A, Gupta D, Ravi A. Tethered cord syndrome: a diagnostic challenge. Pediatr Neurosurg. 2003;38(5):271-278. PMID: 12686823.
  7. Bhaskara S, Rao KN, Bhaskara B, Bhaskara RS. Surgical outcome of type I split cord malformation in children. J Pediatr Neurosci. 2014;9(1):16-21. DOI: 10.4103/1817-1745.131468. PMID: 24891892.
  8. Unsinn KM, Geley T, Freund MC, Gassner I. US of the spinal cord in newborns: spectrum of normal findings, variants, congenital anomalies, and acquired diseases. Radiographics. 2000;20(4):923-938. DOI: 10.1148/radiographics.20.4.g00jl01923. PMID: 10903688.
  9. Schijman E. Split spinal cord malformations: report of 22 cases and review of the literature. Childs Nerv Syst. 2003;19(2):96-103. DOI: 10.1007/s00381-002-0675-y. PMID: 12655421.
  10. Kim S, Chung SK, Rhee K, et al. Clinical outcomes of split cord malformation surgery in a Korean tertiary center. J Korean Neurosurg Soc. 2020;63(3):372-380. DOI: 10.3340/jkns.2019.0188. PMID: 32406653.